Positive pressure ventilation in patients with obstructive lung disease may result in over-inflation of the relatively compliant lungs, resulting in dynamic hyperinflation (DHI). Using a crossover trial design, we compared high-frequency jet ventilation (HFJV) versus "optimal" intermittent positive pressure ventilation (IPPV) in ten patients undergoing lung transplantation for severe, end-stage obstructive lung disease. We measured haemodynamics and the degree of DHI after both modes of ventilation. There were no significant differences between IPPV and HFJV, with respect to efficiency of ventilation (P a CO 2 ), haemodynamic effects (stroke volume, blood pressure and cardiac output), or lung hyperinflation (trapped gas volume). This study suggests that HFJV, when compared with optimal IPPV, is no better at minimizing DHI in patients with severe, end-stage obstructive lung disease.
At our institution we are presented with many patients with severe, end-stage obstructive lung disease who are undergoing single lung, bilateral sequential lung, or heart-lung transplantation. Anaesthesia and positive pressure ventilation in patients with obstructive lung disease, particularly those with bullous disease, is potentially associated with many complications. Expiratory airflow obstruction may result in over-inflation of the relatively compliant lung, a situation referred to as "gas trapping", "auto-PEEP" or dynamic hyperinflation (DHI) [1] [2] [3] . This may lead to circulatory instability due to a tamponade effect, bulla rupture, pneumothorax (often under tension) and mediastinal emphysema [3] [4] [5] [6] [7] .
The aim of this study was to investigate the use of high-frequency jet ventilation (HFJV) in these patients, with a prospective, randomized, single-blind crossover design. HFJV has the theoretical and anecdotal advantages of minimizing high airway pressure and therefore over-distension of lung bullae [6] [7] [8] . HFJV was compared to conventional intermittent positive pressure ventilation (IPPV) immediately after induction of anaesthesia and institution of positive pressure ventilation.
METHODS
After Ethics Committee approval and informed consent, ten adult patients with end-stage obstructive lung disease undergoing lung transplantation were studied. All had significant "gas trapping" noted during previous lung function testing. Patients were not included if they had a pre-existing lung air leak.
Anaesthetic Technique
All patients were assessed preoperatively by the anaesthetist and the patient's routine bronchodilators were given before transfer to theatre. Premedication consisted of oral temazepam or intramuscular midazolam. On arrival in the operating room, electrocardiograph (ECG) and pulse monitoring was established. Intravascular catheters (systemic arterial, central venous and pulmonary arterial) were inserted under local anaesthesia and sedation, allowing administration of vasoactive drugs and invasive monitoring. A thoracic epidural was inserted before induction of anaesthesia and 2 to 5 ml of 0.5% bupivacaine solution was administered. Anaesthesia was then induced with intravenous diazepam 2 to 10 mg, fentanyl 500 to 1000 µg and thiopentone 50 to 250 mg, with muscle relaxation provided by suxamethonium 100 mg and pancuronium 6 to 12 mg. Anaesthesia was maintained with further increments of fentanyl, isoflurane (during IPPV) and a propofol infusion (during HFJV); no nitrous oxide was used.
Ventilator Management
Endotracheal intubation occurred following rapid sequence induction, using either a Univent endotracheal tube (Fuji Systems Corporation, Tokyo, Japan), size 8.5 mm ID, or a 39FG Bronchocath double-lumen tube (Mallinckrodt Inc, NY, U.S.A.). Eventual endobronchial placement and lung isolation occurred after the trial period in order to ensure adequate bilateral lung ventilation. Correct placement was confirmed with fibreoptic bronchoscopy. The order in which each mode of ventilation was used was determined from a table of random numbers.
IPPV was provided by a Campbell Mk. 5 ventilator (ULCO Medical, Sydney, Australia). Using an inspired oxygen fraction (FiO 2 ) of 1.0, the settings were: tidal volume (V T ) 10 ml/kg, rate 8 breaths/min and inspiratory:expiratory (I:E) ratio 1:5. This was achieved with an inspiratory flow rate of 60 to 100 l/min, accepting high peak airway pressures (Paw). These settings were chosen to maximize expiratory time and so minimize DHI: "optimal IPPV" 5, 9, 10 .
HFJV was provided by a Bear Jet Ventilator (Bear Medical Systems, Inc. Riverside, California, U.S.A.), using 100% oxygen at a drive pressure of 30 psig (♠200 kPa), inspiratory time 15% and rate 150 breaths/min. The entrainment gas was room air via the open end of the jet connector. No humidification of the jet gases was provided unless the HFJV was used beyond the 30 minute trial period, in which case a constant infusion of normal saline at 20 ml/hr was delivered via a syringe pump.
All studies were undertaken during the period between induction of anaesthesia and sternotomy/ thoracotomy. Each ventilation mode was used for 15 minutes, separated by one minute of apnoea (a "washout" period), in order to avoid a carryover effect. From previous experience it was expected that ventilator settings during both periods would achieve a partial pressure of arterial carbon dioxide (P a CO 2 ) of approximately 55 to 60 mmHg. At the end of the trial period, all patients were subsequently managed according to the best ventilation mode established during the trial.
Cardiac output was measured using the thermodilution method (10 ml of room-temperature saline at end-expiration (during IPPV only), averaged over three measurements within 10% of each other). The endpoints of interest were P a CO 2 , mean systemic blood pressure (mBP), stroke volume (SV), cardiac output (CO) and the volume of gas trapped (V GT ). V GT was measured after each period of ventilation (IPPV, HFJV) following an apnoeic period (prolonged expiratory pause) of 1 min, in which the expired gas volume (V E ) was collected into a lowresistance bellows. V GT was calculated as V E -V T 2, 9 . Inotrope requirements were also recorded.
Statistics
Data are presented as mean (standard deviation, SD) or, if skewed, as median (interquartile range). The difference and average of the two ventilator periods were first calculated to exclude a period or sequence effect 11 . As both of these preliminary analyses were negative (P greater than 0.1), we proceeded with a comparison between groups using paired Student's t test or the Wilcoxon matched pairs signed ranks test. SPSS V4.0 software was used for statistical analyses and a P value of less than 0.05 was considered significant.
RESULTS
Six male and four female patients were enrolled in the study. Their underlying conditions included cystic fibrosis (n=4), bronchiectasis (n=3), alpha 1antitrypsin deficiency (n=1), bullous sarcoid (n=1) and idiopathic emphysema (n=1). Those with cystic fibrosis and bronciectasis underwent bilateral sequential lung transplantation; the remainder underwent single lung transplantation. Their characteristics are listed in Table 1 . There were no significant differences between IPPV and HFJV, with respect to efficiency of ventilation (using P a CO 2 ), haemodynamic effects (using SV, mBP and CO), or lung hyperinflation (using V GT ) (see Table 2 and Figure 1 ). No patient suffered from barotrauma, nor required specific inotrope therapy for hypotension during the study period.
DISCUSSION
This study suggests that HFJV, when compared to optimal IPPV, is no better at minimizing DHI in patients with severe, end-stage obstructive lung disease. This was a prospective, randomized, crossover trial with an appropriate washout period, with preliminary analyses to detect period effect and a treatment-period interaction. Clear predetermined objective outcome measures were used.
DHI also referred to as "auto-PEEP" or "gas trapping", has been described in patients with obstructive airways disease following cardiopulmonary resuscita-tion 4, 12, 13 , in intensive care 2, 9, 14 , lung transplantation 3, 10, 15 , and also during non-cardiothoracic surgery 16 . We have also detected various degrees of DHI in our patients undergoing lung volume reduction surgery. Despite its importance, it often remains unrecognized and cardiac arrest may ensue. DHI may develop whenever the V T is great enough to prevent passive exhalation of the delivered V T within the given expiratory period 2, 10 . The haemodynamic consequences of DHI relate to the increase in intrathoracic pressure, with reduction of venous return to the heart. This, in effect, is a form of cardiac tamponade. Patients with compliant lungs, such as in emphysematous or bullous lung disease, transmit a greater proportion of intra-alveolar pressure to the great vessels and heart and are therefore at greater risk of circulatory depression. Hypovolaemia will potentiate this process.
Tuxen and Lane 9 found that the major determinants of DHI in asthmatic patients include V T , expiratory time, and severity of airflow obstruction. They found that DHI could be minimized with a V T of 8-10 ml/kg, and maximizing expiratory time by decreasing the inspiratory time with an increase in inspiratory flow rate to 80-100 l/min (I:E ratio of at least 1:4). They concluded that lung hyperinflation and not peak inspiratory pressure may be the more important cause of barotrauma. This has led to increasing acceptance of "permissive hypercapnia" in the ventilator management of patients with airway obstruction 17, 18 . We have previously described details of several patients with DHI who suffered cardiac arrest after commencement of positive pressure ventilation and their successful intra-operative ventilator management 3, 16 .
There are a number of reasons why we could not find a difference between the two modes of ventilation. It is possible that the sample size chosen was not adequate to detect an improvement with HFJV. However, we chose a high-risk group of patients with proven severe hyperinflation on previous lung function testing. We were able to demonstrate a degree of DHI in most of them, and the reason why we were not confronted with severe DHI was, we believe, because of the optimal IPPV settings (as described) and the likelihood that HFJV may be less prone to DHI in general. We also used isoflurane, a bronchodilating anaesthetic agent, during the period of IPPV, whereas we used propofol during the period of HFJV. This may have reduced the likelihood of DHI during the period of IPPV, but because of the short time periods, we do not believe this would have been significant. 473 
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Anaesthesia and Intensive Care, Vol. 25, No. 5, October 1997 Although the 15 minute time periods may appear too short to develop DHI, we had previously experienced severe, life-threatening DHI early after induction of anaesthesia and institution of IPPV 3, 10, 16 . Since March 1990 we have managed more than 170 patients undergoing lung transplantation and because of our heightened awareness, are infrequently confronted with serious haemodynamic effects. We would like to stress that this is because of our awareness of the potential problem of DHI and our ventilator management, including permissive hypercapnia.
Our study does not show that HFJV has any advantages over optimal IPPV, so we are left with several potential disadvantages including atelectasis, technical mishaps resulting in barotrauma, difficulty with the provision of adequate humidification and reliance on intravenous anaesthesia. Conacher 8 has described "prolonged interval" jet ventilation in 17 patients having various forms of lung surgery. He used a series of three to nine pulses of jet ventilation followed by a 10 to 50 second pause, allowing lung deflation to occur. One patient suffered a tension pneumothorax and hypercapnia was common, though he concluded that a comparative clinical trial was warranted. A similar lack of clear benefit was demonstrated by Schuster and co-workers 19 in nine patients with acute respiratory failure, where they could not demonstrate improvement in oxygenation with HFJV. There are many and varied descriptions of HFJV, which may affect CO 2 clearance, airway pressure and DHI 8, [19] [20] [21] [22] [23] [24] [25] . For instance, Gaughan and co-workers 25 demonstrated in a lung model that DHI may result unless an I:E ratio of at least 1:3 is used. Our HFJV settings were determined before commencement of the study, after assuring ourselves that they would result in normocapnia in a healthy lung population, and, theoretically at least, minimize the risk of DHI.
Although DHI is a common cause of hypotension following institution of IPPV in patients with severe airways obstruction, other causes should also be considered: drug-induced vasodilation or anaphylactoid reaction, tension pneumothorax or hypovolaemia. These conditions may also co-exist with DHI, and certainly the haemodynamic consequences of DHI can be partly corrected by fluid replacement and inotrope therapy. Nevertheless, the primary response should remain correction of DHI, through a decrease in ventilation and acceptance of hypercapnia. We have managed many patients during bilateral sequential lung transplantation with very high levels of P a CO 2 (to 120 mmHg), without apparent adverse sequelae; this has also been reported by others 15 . In fact, we believe that such ventilator management has assisted us in avoiding cardiopulmonary bypass in over 80% of cases. If bullous rupture or tension pneumothorax occurs intra-operatively in a patient with bullous lung disease, then subsequent urgent management may include HFJV, because of the lower mean airway pressure and maintenance of alveolar ventilation, when compared to conventional IPPV 26 . Alternatively, optimal IPPV, as described above, and avoidance of nitrous oxide (which may result in enlargement of air-filled spaces) 27 can be used. Regardless, this study suggests that HFJV, when compared to optimal IPPV, is no better at minimizing DHI in patients with severe, end-stage obstructive lung disease.
